logo
  Join        Login             Stock Quote

Mednax (MD) Downgraded To 'Hold' By Deutsche Bank, PT Cut To $73

 May 04, 2012 01:04 PM


(By Balachander) Mednax Inc. (NYSE:MD) shares were downgraded to "Hold" from "Buy" and price target lowered to $73 from $81 by Deutsche Bank analyst Darren Lehrich.

"Our U/G last Oct was predicated on growth in the core business stabilizing in the 3% to 3.5% range, and much greater potential earnings upside / multiple expansion from an accelerating M&A trend," the analyst wrote.

Lehrich acknowledges that it is still early in MD's anesthesia M&A trajectory. "Yet, we fear the co's slower pace of deals, coupled with a change in the co's margin profile due to the mix of acquired businesses, will lead to less multiple expansion than originally thought," he said.

[Related -Stock Upgrades And Downgrades: BBBY, DD, LULU, MASI, PETM, RDC, SYY]

The analyst said YTD acquisition announcements are pacing below his original expectations. "The confluence of deal pacing, a slightly lower S-U growth outlook by mgmt (to +1.5% to +3.5% or down 100 bps from prior), and mix/margin issues – lead MD's Q2 guidance to imply pretty flat yoy EPS growth. We see this outlook as a real disappointment, and indicative of potentially weaker underlying trends."

"Key downside risks: Medicaid mix, pricing, timing of M&A. Key upside risks: pot'l for Medicaid PCP code changes, M&A, buyback," the analyst said.

Sunrise, Florida-based Mednax provides neonatal, maternal-fetal, other pediatric subspecialties, and anesthesia physician services in the United States and Puerto Rico.

The stock, which has been trading in the 52-week range of $58.48 to $75.86, fell 3.7 percent to trade at $64.69 on Friday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageOld Bank's New Breakout has Big Rally Potential

One of my favorite things to see in a long candidate is a pattern of beating Wall Street's earnings read on...

article imageIs The Stock Market's 5-Year Return A Useful Proxy For Valuation?

Tobin’s Q, a market-valuation metric, is back in the news, in part thanks to a widely read Bloomberg read on...

article image4 Dogs To Sell Immediately

Despite the chorus of analysts and investors calling for the long-awaited correction, the market is showing read on...

article imageThe Fed's Magical Mystery Tour

What's going on at the Fed? Notorious dove, Charles Evans of the Chicago Fed, gave a speech in read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.